For the Quarter Ending September 2025
North America
• In the USA, the Acesulfame Potassium Price Index fell by 1.79% quarter-over-quarter, reflecting inventory normalization.
• The average Acesulfame Potassium price for the quarter was approximately USD 4657.33/MT, reflecting traded levels.
• Tight distributor inventories tightened Acesulfame Potassium Spot Price, pressuring the Price Index upward short periods.
• Exporters adjusted offers higher in August, supporting the Acesulfame Potassium Price Forecast for near-term demand.
• Stable feedstock ensured Acesulfame Potassium Production Cost Trend, limiting supply-driven volatility in the Price Index.
• Broad food and beverage orders underpinned the Acesulfame Potassium Demand Outlook, sustaining modest upward pressure.
• Distributors balanced capital and safety stocks, moderating activity and influencing the Acesulfame Potassium Price Index.
• Major exporters maintained production and shipments, relieving shortages yet keeping Acesulfame Potassium Spot Price firm.
Why did the price of Acesulfame Potassium change in September 2025 in North America?
• Distributor inventory tightness and downstream procurement triggered upward pressure on the Acesulfame Potassium Price Index.
• Stable feedstock and uninterrupted exports limited cost-driven increases, keeping Acesulfame Potassium Production Cost Trend benign.
• Efficient logistics and steady freight rates enabled arrivals, while discretionary buying drove Acesulfame Potassium demand.
APAC
• In China, the Acesulfame Potassium Price Index fell by 2.06% quarter-over-quarter, reflecting weaker export demand.
• The average Acesulfame Potassium price for the quarter was approximately USD 4503.33/MT, reflecting balanced procurement.
• Acesulfame Potassium Spot Price firmed as tight export inventories coincided with accelerated beverage sector procurement.
• Acesulfame Potassium Demand Outlook remains steady with continued orders from beverage, oral care, pharmaceutical sectors.
• Acesulfame Potassium Price Forecast suggests modest upward bias into autumn before anticipated normalization thereafter period.
• Acesulfame Potassium Production Cost Trend remained benign as sulfamic acid feedstock availability stayed stable throughout.
• Acesulfame Potassium Price Index was moderated by efficient logistics, smooth port operations, stable freight rates.
• Producers operated reliably with minor maintenance; exporters saw moderate bulk inquiries sustaining short-term price support.
Why did the price of Acesulfame Potassium change in September 2025 in APAC?
• Export restocking in June created inventories, then softer orders in September reduced spot demand urgency.
• Stable feedstock availability and uninterrupted logistics limited production cost pressures, preventing notable upward price movement.
• Moderate inventories and balanced export inquiries resulted in measured procurement, prompting mild quarter-end price correction.
Europe
• In Germany, the Acesulfame Potassium Price Index fell by 1.67% quarter-over-quarter, reflecting easing demand pressures
• The average Acesulfame Potassium price for the quarter was approximately USD 4610.33/MT per CFR Hamburg
• Acesulfame Potassium Spot Price eased in July and August as buyers drew down distributor inventory
• Acesulfame Potassium Price Forecast points to modest autumn firmness driven by seasonal restocking demand levels
• Acesulfame Potassium Production Cost Trend remained muted with freight and currency variations affecting landed costs
• Acesulfame Potassium Demand Outlook supports reformulation-driven buying, prompting cautious replenishment by domestic processors and distributors
• Acesulfame Potassium Price Index tightened after concentrated June bookings, easing as inventories normalized in July
• Export availability was steady, but selective front-loading by buyers tightened spot supply, keeping offers firm
Why did the price of Acesulfame Potassium change in September 2025 in Europe?
• Inventory normalization after June front-loading reduced immediate buying, easing upward price momentum in September 2025
• Stable export flows and smooth logistics limited supply shocks while currency shifts improved import economics
• Downstream demand plateau and elevated distributor stocks prompted order delays, contributing to modest quarterly decline
For the Quarter Ending June 2025
North America
• Acesulfame Potassium Spot Price rose sharply in June 2025 by 6.13% to USD 4935/MT (CFR Houston) amid a strong surge in downstream demand from the beverage, processed food, oral care and pharmaceutical sectors that was coupled with proactive procurement activity.
• Acesulfame Potassium Price Forecast indicated bullish sentiment during June as strategic forward-buying by U.S. distributors created tight inventories ahead of Q3 in preparation for summer-driven demand and Q3 pricing adjustments.
• April 2025 saw a 3.89% decline in Acesulfame Potassium Spot Price that reflected a weak market confidence, tariff uncertainties on Chinese-origin imports, and high carryover stocks that discouraged fresh orders.
• May 2025 brought price stability with a marginal 0.17% increase as surplus inventory absorption and moderate order resumption from the medical, pharmaceutical, and F&B sectors helped reset a cautious but improved market baseline.
• Acesulfame Potassium Production Cost Trend remained stable in Q2, with uninterrupted overseas production. However, intensified American import volumes created temporary pressure on global allocations.
• The U.S. market’s demand was reinforced by expanded zero-calorie beverage portfolios, sugar-free oral care products, and diabetic-friendly pharma formulations, driving sustained Acesulfame Potassium Demand Outlook.
• Import logistics operated efficiently throughout the quarter, with smooth port clearances and no inland transportation issues—allowing buyers to focus more on forward procurement strategies than on operational risks.
• The Price Index for Acesulfame Potassium in June reflected a clear transition from inventory-driven caution (April) to demand-led acceleration (June), highlighting the evolving market dynamics through the quarter.
• Why did the price change in July 2025?
Prices in North America are expected to increase further in July 2025 as downstream inventories remain tight, and processors are likely to intensify orders ahead of Q3 launches and holiday stocking. Continued demand from beverages and functional foods alongside summer promotions will exert upward pressure on the Acesulfame Potassium Spot Price and shape a bullish Acesulfame Potassium Price Forecast.
Asia-Pacific
• In June 2025, the Acesulfame Potassium Spot Price rose 4.87% to USD 4740/MT (FOB Shanghai) due to robust regional and international demand, especially from diet beverage, functional food, and pharma segments, which significantly drew down inventories.
• Acesulfame Potassium Price Forecast turned bullish in June, following a stable May, as producers faced high offtake levels and limited stock build-up despite steady output across major Chinese plants.
• April 2025 witnessed a steep 4.14% drop in spot prices, primarily because of sluggish domestic demand, tariff-driven weak export performance, and overstocking by pharma and nutraceutical buyers in Q1.
• May 2025 marked stabilization with a marginal 0.31% decline in the Acesulfame Potassium Spot Price, indicating that excess stocks were successfully absorbed into production cycles, and new orders began to trickle in.
• Acesulfame Potassium Production Cost Trend in APAC remained consistent during Q2 due to uninterrupted operations, except for a short shutdown at Shandong Minghui Food Co., Ltd in June. No raw material bottlenecks or policy disruptions were reported.
• APAC's Acesulfame Potassium Demand Outlook was lifted by regional dietary shifts towards low-GI, plant-based, and clean-label products, with especially strong procurement from oral care, functional beverages, and diabetic product manufacturers.
• Export channels from China remained efficient throughout Q2, with no inland logistics issues. However, exportable volumes were tight in June due to heightened global interest, prompting upward pricing adjustments.
• The Price Index trajectory through Q2 shows a V-shaped recovery — sharp drop in April, stabilizing in May, and sharp gain in June — driven by inventory normalization and renewed buyer engagement.
• Why did the price change in July 2025?
July prices in APAC are expected to rise further as demand intensifies from ASEAN and South Asian markets entering peak consumption periods. Procurement from regional buyers is projected to rise amid summer beverage and health product production cycles, contributing to a tight Acesulfame Potassium Spot Price environment and an upward Price Forecast, despite stable production conditions.
Europe
• Acesulfame Potassium Spot Price in June 2025 increased by 5.55% to USD 4850/MT (CFR Hamburg) driven by strong restocking from German food, pharma, and oral care sectors, combined with anticipation of Q3 price hikes and compliance-driven reformulation efforts.
• Acesulfame Potassium Price Forecast in Europe entered a bullish phase as food and beverage formulators moved to meet mandatory sugar-reduction guidelines, boosting short-term procurement momentum.
• In April 2025, the Price Index dropped by 4.03%, reflecting exporter-led markdowns to clear stocks and subdued buying interest across the EU. Importers were hesitant due to sluggish retail consumption and high legacy inventories.
• May’s Acesulfame Potassium Spot Price edged down 0.56%, showing a plateau as stock drawdowns helped restore equilibrium, though buyers still followed a conservative procurement approach.
• Acesulfame Potassium Production Cost Trend remained stable across exporting markets in Q2, but volatile freight rates in June caused a slight lift in landed costs, adding pressure to European import prices.
• Acesulfame Potassium Demand Outlook across Germany was robust by June, anchored in regulatory reformulations, summer-driven food/beverage campaigns, and increased sugar-free pharma formulations—each reinforcing procurement sentiment.
• German ports and inland logistics remained efficient throughout the quarter, allowing consistent throughput. However, synchronized restocking activity across downstream sectors in June led to temporary supply tightness at distributor levels.
• The Q2 Price Index in Europe showed a two-phase trend: April–May saw pricing contraction or neutrality due to overstocked channels, followed by a sharp spike in June led by regulation-driven and seasonal restocking.
• Why did the price change in July 2025?
Prices are anticipated to increase further in July 2025 across European markets, especially Germany, due to continued compliance-driven demand, Q3 promotional stocking, and pressure from high-cost logistics. The Acesulfame Potassium Spot Price is expected to firm, with a bullish Price Forecast as new procurement cycles resume to meet upcoming health food and pharmaceutical campaigns.
For the Quarter Ending March 2025
North America
In North America, Acesulfame Potassium prices averaged a decline of 1.76% through the first quarter of 2025. The market remained steady in supply but demand from food, beverage, and nutraceutical manufacturers stayed on the lower side. Cooler weather in the early part of the year often slows production activity in these sectors and this trend continued during the quarter.
Buyers kept procurement cautious and chose to rely on available inventory instead of rushing into fresh purchases. Another factor was the region’s shifting trade landscape with tariffs affecting procurement plans for several imported ingredients. This encouraged more measured buying and softened the pace of market transactions. Logistics services operated smoothly without major delays and kept the supply chain well managed.
Despite steady availability, downstream industries showed no urgency for extra stock. By late March, some market participants hinted at mild restocking plans for the coming quarter, but sentiment overall stayed careful. A balanced market environment combined with subdued buying interest helped further in pushing prices to a soft decline without sharp fluctuations during the first quarter of 2025.
Asia Pacific
In Asia Pacific, Acesulfame Potassium prices recorded a modest average drop of 0.76% during the first quarter of 2025. The market experienced a typical seasonal transition, which naturally slowed product movement in certain sectors. Early in the quarter, a holiday period across several key countries temporarily reduced production and procurement activity.
Following the holiday period the downstream sectors like food, beverages and nutraceuticals continued with restrained purchasing. Many manufacturers were seen working through existing inventories and delayed fresh orders in anticipation of better pricing opportunities. Logistics operations remained smooth throughout the quarter, avoiding any disruptions in supply. At the same time the availability of the product remained steady which further resulted in prices showing a downward trend.
Procurement strategies were focused on small and requirement-based purchasing was done instead of bulk buying. By March end, overall demand levels did not pick up significantly and kept the market quiet. Seasonal transition and a preference for cautious buying patterns shaped the price movement during this period. The market closed the quarter in a balanced state, with no major supply issues but only moderate demand from downstream industries.
Europe
The European market saw Acesulfame Potassium prices ease by an average of 1.86% during the first quarter of 2025. Downstream demand from food, beverage and personal care sectors stayed moderate. Cold seasonal conditions in January and February traditionally reduce output in these categories and this year followed a similar pattern.
Manufacturers were cautious with procurement and maintained only routine purchases to support day-to-day production. Inventory levels across key buyers were reported to be comfortable and helped in reducing the need for aggressive sourcing. Supply chains remained unaffected through the quarter and ensured a smooth availability of the product. This stable supply, combined with weak demand created soft market conditions and limited the potential for price support.
Additionally, nutraceutical manufacturers in the region adjusted output in response to shifting consumer trends and cost controls which further impacted demand. As the quarter progressed the sentiment within the market stayed quiet with limited expectations for a near-term improvement. By March end, the pricing environment reflected steady supply and cautious downstream purchasing behaviour and resulted in a consistent but gradual price pressure.
For the Quarter Ending December 2024
North America
In the fourth quarter of 2024, the U.S. Acesulfame Potassium market saw significant price fluctuations with a modest drop in December. Early in the quarter, prices surged due to increased seasonal demand from the food and beverage industry.
Elevated shipping costs from Asian suppliers, driven by rising fuel charges and supply chain disruptions, particularly at New York terminals, contributed to higher landed costs. Limited domestic production capacity and port congestion, worsened by labor actions from the International Longshore and Warehouse Union (ILWU), further strained logistics. Additionally, businesses engaged in strategic stockpiling amidst rising feedstock costs, sustaining upward price pressure. However, by December 2024, the market experienced a decline in import prices. This was primarily due to weakened demand from critical sectors such as pharmaceuticals and food, compounded by high buyer inventories.
Reduced purchasing activity and intensified competition from Chinese imports placed downward pressure on prices. The market remained subdued, with a lack of confidence in a near-term recovery, driven by lower Manufacturing PMI and cautious buying strategies. High input costs and weak demand led to oversupply conditions, prompting aggressive destocking and competitive pricing strategies. Consequently, Acesulfame Potassium prices continued to reflect challenges in the supply chain and declining demand across key sectors.
Asia Pacific
In the fourth quarter of 2024, the Chinese Acesulfame Potassium (Ace-K) market experienced a turbulent period marked by both upward and downward price movements. October saw a notable price surge driven by rising overseas demand for sugar substitutes, particularly from health-conscious regions like North America and Europe. However, the market also faced challenges, including disruptions from a severe typhoon that led to shipping delays, freight cost hikes, and heightened buyer activity due to upcoming holidays. Additionally, the appreciation of the U.S. dollar against the yuan further impacted the market, with import prices rising, while profit margins for traders improved. Despite this, the overall market environment remained complex, as domestic production constraints and import dependencies led to a sellers' market scenario in October. By November, export prices for Acesulfame Potassium faced downward pressure due to reduced overseas demand and increased inventories, exacerbated by an expansion in domestic production. This shift contributed to a cautious approach from downstream industries, further weighing prices. Meanwhile, China’s economic indicators, such as the Manufacturing PMI, reflected moderate growth but struggled to alleviate the weak trading sentiment. The market entered a buyers' market phase, with price pressures expected to persist due to inventory glutes, reduced external demand, and ongoing uncertainties around trade policies.
Europe
In the fourth quarter of 2024, the German Acesulfame Potassium market exhibited dynamic trends shaped by fluctuating economic conditions and global market influences. In October, prices showed a steady upward trajectory, driven by elevated raw material costs, persistent logistical challenges, increased freight charges from China and India, and energy cost pressures in Europe. The depreciation of the euro further exacerbated import costs, limiting access to lower-priced imports and favoring quality-compliant, higher-priced options. Meanwhile, Germany's Manufacturing PMI reflected a slight improvement, rising to 43 in October from a twelve-month low of 40.6 in September, signaling a potential economic trough despite ongoing contraction. By November, import prices for Acesulfame Potassium experienced a steady decline, mirroring trends across the artificial sweetener sector. This was driven by weakened demand from the food and beverage industry, higher inventory levels, and competitive pricing from Asian exporters benefiting from cost-efficient manufacturing. However, port delays and workforce shortages due to seasonal disruptions slightly strained supply chains. Despite these challenges, muted downstream demand and the euro’s continued devaluation resulted in cautious, need-based procurement strategies. Suppliers faced pressure to reduce high inventory levels through aggressive pricing, creating a buyer's market and underscoring the need for adaptive supply chain strategies. This trend continued until the final week of December, sustain an pessimistic trading sentiments.
